CA
NZ
UK
AU
IND
US
● QTREX Quantum rocketed after already jumping in premarket trading, extending gains through the session.
● Sunshine Biopharma plunged with no press release, filing, trial update or financing announcement found to explain it.
● The FDA approved a secondManufacturingsuite for Alvotech's SIMLANDI, its biosimilar to AbbVie's Humira.
● HeartBeam skyrocketed with no company-specific news, press release or filing found to explain the move.
● Genmab's epcoritamab combination "reduced the risk of disease progression or death" versus R-CHOP alone in a Phase 3 trial.
● UnitedHealth finished as the third-best performer on the Dow, with no company-specific news behind the gain.
● Pfizer slipped with no confirmed company-specific news, part of a broader health care sector decline.
● Stryker rose with no confirmed company-specific news, moving in step with other medical-device makers.
● Thermo Fisher rose alongside a broad rally in life-science tools stocks including Charles River and Danaher.
● No confirmed company-specific release was identified behind the advance.
Please wait processing your request...